Teceleukin
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Japanese patients with neuroblastoma completing induction therapy and high-dose chemotherapy received antidisialoganglioside…
Human Vγ2 Vδ2-bearing T cells have recently received much attention in cancer immunotherapy. In this study, we conducted a phase…
PurposeAlthough various types of immunotherapy have been used to improve the prognosis of patients with advanced renal cell…
se of drug eruption after long term rIL-2 therapy is reported.A 67-year-old man had a tumor on his right temporal scalp on June…
SynopsisRecombinant interleukin-2 (IL-2) products (e.g. aldesleukin, teceleukin) are nonglycosylated, modified forms of the…
The chemical properties, pharmacology, immunology, pharmacokinetics, clinical trials, adverse effects, and dosage and…
Fifteen patients with advanced, measurable renal cell carcinoma entered a Phase II clinical trial of interleukin‐2 (IL‐2…
Fifteen patients with advanced, measurable renal cell carcinoma entered a Phase II clinical trial of interleukin-2 (IL-2…
Single doses of teceleukin ranging from 0.1 to 30 x 10(6) units were administered to cancer patients as intravenous infusions or…
Single doses of teceleukin ranging from 0.1 to 30 x 10(6) units were administered to cancer patients as intravenous infusions or…